U.S. Patent 7,921,028

The architecture behind the creator marketplace.

IndieRiser owns active U.S. patent rights covering a technology workflow that connects creators with content partners—from evaluation and matching to invitations for rights, exclusivity, and queues.

System view Active patent

One patent. A connected commercial workflow.

Creator profilesContent reviewPartner matchingRights accessExclusivity
01 / The asset

Built before the creator economy had a name.

The patent describes systems and methods for partnering content creators with content partners online. Its claims address the connective logic that turns content discovery into a structured commercial pathway.

Priority date 2005

April 12, 2005

Issued claims 28

System and method claims

Owner IndieRiser

IndieRiser LLC

02 / Explore the workflow

A connected system—not a single feature.

Select each stage to see how the patented architecture moves creative content from submission toward a rights transaction.

The creator enters the system

Register creators, partners, and preferences.

Profiles organize the parties, their qualifications, and the types of creative content a partner wants to receive.

RegistrationProfilesPreferences
1 / 5

This overview is illustrative. Product-specific claim mapping is available for confidential review.

03 / Licensing pathway

A practical path to patent licensing.

IndieRiser is prepared to engage with companies whose products connect creators, content, brands, advertisers, buyers, or distribution partners.

LICENSE REVIEW

Move from diligence to a negotiated license.

A focused review can help evaluate the patent's relevance, address patent risk, and support a practical commercial resolution.

  • 01 Product-specific claim analysis
  • 02 Confidential technical discussion
  • 03 Commercial licensing framework
Discuss licensing
04 / Confidential review

See how the patent maps to your platform.

IndieRiser can provide a focused claim chart and discuss licensing under appropriate confidentiality terms.

Request a confidential review